V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006128 | 200014631 | 1.77 | 103.2 | Palliative (P) | 2020-01-16 | 2020-01-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101012400 |
| 200006131 | 200014632 | 0 | 0 | null | 2017-11-06 | 2017-11-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101859991 |
| 200006132 | 200014633 | null | 55.6 | Palliative (P) | 2019-04-13 | 2019-05-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100410319 |
| 200006133 | 200014634 | 0 | 0 | Palliative (P) | 2016-10-07 | 2016-10-07 | null | 02 | null | TRIAL UNSPECIFIED | 101138898 |
| 200006134 | 200014635 | 1.81 | 64 | Palliative (P) | 2017-03-18 | 2017-04-15 | Binimetinib + Encorafenib | 02 | N | DABRAFENIB | 101138583 |
| 200006138 | 200014638 | 1.62 | 94.5 | null | 2021-10-21 | 2021-12-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101366725 |
| 200006139 | 200014639 | 1.84 | null | Adjuvant (A) | null | 2020-09-23 | null | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101744501 |
| 200006140 | 200014640 | 1.72 | 79 | Palliative (P) | 2018-07-24 | 2019-11-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101067014 |
| 200006141 | 200014641 | 1.71 | 103.8 | Palliative (P) | 2019-03-17 | 2019-03-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100233963 |
| 200006149 | 200014647 | 1.78 | 106.1 | Palliative (P) | 2020-12-22 | 2020-12-29 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101066883 |
| 200006150 | 200014648 | 1.65 | 75.7 | Palliative (P) | null | 2019-05-15 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | TRIAL UNSPECIFIED | 100585138 |
| 200006153 | 200014650 | 1.67 | 68 | Palliative (P) | 2019-01-17 | 2019-05-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101188323 |
| 200006154 | 200014651 | null | 86 | Palliative (P) | 2020-01-29 | 2020-02-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100319156 |
| 200006155 | 200014652 | 1.72 | 77 | Curative (C) | 2018-05-01 | 2018-05-08 | null | 02 | null | TRIAL UNSPECIFIED | 100189723 |
| 200006158 | 200014654 | 1.55 | 78.1 | Palliative (P) | 2018-12-30 | 2019-01-13 | DABRAFENIB | 02 | null | DABRAFENIB | 101092425 |
| 200006159 | 200014655 | null | null | null | null | 2021-10-27 | null | null | null | BINIMETINIB + ENCORAFENIB | 101196930 |
| 200006164 | 200014658 | null | 95.6 | Palliative (P) | 2019-06-24 | 2019-07-01 | Ipilimumab | 02 | null | IPILIMUMAB | 101186243 |
| 200006167 | 200014661 | 1.65 | 79.5 | Palliative (P) | 2019-06-06 | 2019-08-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100494113 |
| 200006168 | 200014662 | 1.84 | null | Palliative (P) | 2021-05-09 | 2021-05-15 | IPILIMUMAB + NIVOLUMAB | N | N | IPILIMUMAB + NIVOLUMAB | 101159108 |
| 200006169 | 200014663 | 1.69 | 71.6 | Palliative (P) | 2019-05-07 | 2019-05-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100689510 |
| 200006172 | 200014666 | 1.68 | 59.9 | Palliative (P) | 2018-08-11 | 2018-08-13 | DABRAFENIB | 02 | N | DABRAFENIB | 101679844 |
| 200006173 | 200014667 | 1.82 | 66 | Palliative (P) | null | 2018-11-12 | Ipilimumab | null | N | IPILIMUMAB | 100188177 |
| 200006176 | 200014669 | 1.65 | 71 | Palliative (P) | 2017-08-15 | 2017-08-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100273925 |
| 200006179 | 200014671 | 1.8 | null | null | 2018-04-16 | 2018-05-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100554040 |
| 200006182 | 200014673 | 1.7 | 53.5 | Palliative (P) | 2016-12-03 | 2016-12-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101367118 |
| 200006188 | 200014676 | null | null | null | 2016-08-10 | 2016-09-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100939256 |
| 200006190 | 200014678 | 1.66 | 80.4 | Palliative (P) | 2021-01-16 | 2021-06-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100168781 |
| 200006193 | 200014679 | 1.7 | 56 | Palliative (P) | 2019-07-20 | 2019-08-27 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100399459 |
| 200006197 | 200014680 | null | 56.1 | Palliative (P) | 2021-05-27 | 2021-05-28 | FEC + TRASTUZUMAB | 01 | null | TRIAL UNSPECIFIED | 100385307 |
| 200006199 | 200014682 | null | 91 | 03 | 2018-08-27 | 2018-09-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101848029 |
| 200006202 | 200014684 | 1.78 | 70 | Palliative (P) | null | 2019-11-17 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100117627 |
| 200006209 | 200014686 | 1.67 | 73.6 | Palliative (P) | 2016-10-21 | 2016-10-31 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100639488 |
| 200006211 | 200014688 | null | 102.6 | Palliative (P) | null | 2019-12-04 | null | null | N | BLEOMYCIN | 100146080 |
| 200006213 | 200014690 | null | 72 | Palliative (P) | 2018-12-10 | 2018-12-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100217840 |
| 200006215 | 200014691 | 1.6 | 75.8 | Palliative (P) | 2017-08-08 | 2017-08-31 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101491202 |
| 200006217 | 200014692 | 1.74 | 85.25 | null | 2018-09-11 | 2018-09-25 | Ipilimumab | null | null | IPILIMUMAB | 100875510 |
| 200006219 | 200014694 | null | null | null | null | 2019-10-03 | null | null | null | HYDROXYCARBAMIDE | 100687233 |
| 200006222 | 200014696 | null | 118 | null | 2017-02-26 | 2017-03-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101036953 |
| 200006224 | 200014697 | null | 92.6 | 03 | 2015-05-18 | 2016-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101224184 |
| 200006225 | 200014698 | 1.69 | 84.4 | Adjuvant (A) | 2021-09-17 | 2021-09-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100866049 |
| 200006230 | 200014701 | 1.68 | 68.8 | Palliative (P) | 2019-07-04 | 2019-09-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100817628 |
| 200006232 | 200014702 | 1.72 | 92.85 | null | 2019-07-23 | 2019-07-24 | Ipilimumab | 02 | null | IPILIMUMAB | 101045589 |
| 200006236 | 200014704 | 0 | 0 | Palliative (P) | 2018-10-24 | 2018-10-26 | DABRAFENIB | 01 | null | TRIAL UNSPECIFIED | 101170715 |
| 200006237 | 200014705 | 1.55 | 97 | Adjuvant (A) | 2021-09-02 | 2021-09-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101648682 |
| 200006239 | 200014707 | null | 77.5 | Palliative (P) | 2020-05-30 | 2020-05-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100695396 |
| 200006240 | 200014708 | null | 51.9 | Palliative (P) | 2020-01-27 | 2020-01-27 | IPILIMUMAB + NIVOLUMAB | 01 | null | TRIAL UNSPECIFIED | 100727387 |
| 200006241 | 200014709 | null | 104.9 | Palliative (P) | 2020-06-03 | 2020-06-16 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101596365 |
| 200006242 | 200014710 | 1.73 | 74 | 03 | 2022-03-23 | 2022-04-04 | Ipilimumab | 02 | null | IPILIMUMAB | 101304948 |
| 200006245 | 200014713 | 1.7 | 52.8 | Palliative (P) | 2017-01-02 | 2017-01-24 | Ipilimumab | null | null | IPILIMUMAB | 101782404 |
| 200006252 | 200014717 | 1.76 | 83.9 | Palliative (P) | 2020-04-20 | 2020-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100980801 |